MAVS and colorectal cancer: A recent study by Roulois et al. [29] showed that low-dose 5-aza-CdR increased the expression of selected HERVs in colorectal cancer cells, reducing the frequency of cancer-initiating cells (CICs) in primary colorectal cancer (CRC) both in vitro and in vivo, via activation of MAVS and IRF7.